The alpha 301 / 302 clinical respiratory therapy devices improve ventilation through recruitment during administration of aerosols through inhalation in case of heavily reduced ventilation reserves or pronounced respiratory failure. Designed to administer oxygen via a central gas supply, they are well-suited for providing continued IPPB therapy for recruitment, secretion management, and drug nebulization in acute care as well as physiotherapy and general care.